Bioventus Inc (BVS)
13.58
+0.01
(+0.07%)
USD |
NASDAQ |
Nov 01, 16:00
13.59
+0.01
(+0.07%)
After-Hours: 20:00
Bioventus Price to Book Value: 5.855 for Nov. 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 5.855 |
| October 31, 2024 | 5.851 |
| October 30, 2024 | 5.855 |
| October 29, 2024 | 5.739 |
| October 28, 2024 | 5.631 |
| October 25, 2024 | 5.696 |
| October 24, 2024 | 5.756 |
| October 23, 2024 | 5.730 |
| October 22, 2024 | 5.592 |
| October 21, 2024 | 5.493 |
| October 18, 2024 | 5.584 |
| October 17, 2024 | 5.411 |
| October 16, 2024 | 5.570 |
| October 15, 2024 | 5.489 |
| October 14, 2024 | 5.420 |
| October 11, 2024 | 5.230 |
| October 10, 2024 | 4.850 |
| October 09, 2024 | 4.945 |
| October 08, 2024 | 4.997 |
| October 07, 2024 | 4.825 |
| October 04, 2024 | 5.066 |
| October 03, 2024 | 5.032 |
| October 02, 2024 | 5.079 |
| October 01, 2024 | 5.083 |
| September 30, 2024 | 5.152 |
| Date | Value |
|---|---|
| September 27, 2024 | 5.027 |
| September 26, 2024 | 4.772 |
| September 25, 2024 | 5.018 |
| September 24, 2024 | 4.941 |
| September 23, 2024 | 4.906 |
| September 20, 2024 | 5.118 |
| September 19, 2024 | 5.006 |
| September 18, 2024 | 5.049 |
| September 17, 2024 | 4.911 |
| September 16, 2024 | 4.777 |
| September 13, 2024 | 4.824 |
| September 12, 2024 | 4.712 |
| September 11, 2024 | 4.548 |
| September 10, 2024 | 4.418 |
| September 09, 2024 | 4.535 |
| September 06, 2024 | 4.116 |
| September 05, 2024 | 4.172 |
| September 04, 2024 | 4.172 |
| September 03, 2024 | 4.315 |
| August 30, 2024 | 4.340 |
| August 29, 2024 | 4.267 |
| August 28, 2024 | 4.185 |
| August 27, 2024 | 4.172 |
| August 26, 2024 | 4.310 |
| August 23, 2024 | 4.284 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2317
Minimum
Mar 29 2023
6.536
Maximum
Nov 03 2021
2.322
Average
1.704
Median
Price to Book Value Benchmarks
| Boston Scientific Corp | 6.045 |
| Insulet Corp | 16.55 |
| Perspective Therapeutics Inc | 2.391 |
| Xtant Medical Holdings Inc | 1.639 |
| Catheter Precision Inc | 0.0995 |
Price to Book Value Related Metrics
| PS Ratio | 1.602 |
| Price to Free Cash Flow | 101.88 |
| Price | 13.58 |
| Earnings Yield | -4.79% |
| Market Cap | 883.74M |
| Operating PE Ratio | 58.51 |